CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.98
+0.01 (+1.11%)
As of Jun 22, 3:11 PM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 7 58%
Hold 4 33%
Sell 1 8%
Price Target
Analyst Price Target +2,303.1% upside
Low Target $17.63
Average Target $23.50
High Target $33.45
Current Price $0.98
Current
$0.98
Target
$23.50
$17.63 $23.50 avg $33.45
Scenario Analysis
Bear Case
$17.63
1,702.8%
Low target
Base Case
$23.50
+2,303.1%
Avg target
Bull Case
$33.45
+3,320.6%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.28
-70.2% from high
52-Week Low
$1.18
+-17.1% from low
Target vs 52W High
$23.50
+616.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%